Jeff Benison

On Wednesday, TheStreet biotech reporter Adam Feuerstein raised alarm that an unknown source paid to convert Seeking Alpha posts about Neurotrope Inc (NASDAQ: NTRP) into unofficial promotional pieces for bryostatin, the company's lead drug candidate. Neurotrope denied any involvement. "The...

Alzheimer's has proven to be one of the most stubborn diseases known to modern medicine. An incurable, devastating illness that inspires frustration — even anger — against and from the scientific community itself, which has failed to develop new, effective therapies. Susanne...

Neurotrope Inc (OTC: NTRP), a clinical stage biopharmaceutical company, may have found through its drug Bryostatin a unique solution to addressing Alzheimer's, one of the last major diseases with no cure. Benzinga recently spoke with CEO Dr. Susanne Wilke, ahead of her appearance at the...